Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type
about
RSV fusion: time for a new modelRoles of nucleolin. Focus on cancer and anti-cancer therapyA nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis.Nucleolin mediates the antiangiogenesis effect of the pseudopeptide N6LEfficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery.Human anti-nucleolin recombinant immunoagent for cancer therapy.Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.Interplay between αvβ3 integrin and nucleolin regulates human endothelial and glioma cell migration.Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model.Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex.Nucleolin-aptamer therapy in retinoblastoma: molecular changes and mass spectrometry-based imagingCell-surface nucleolin acts as a central mediator for carcinogenic, anti-carcinogenic, and disease-related ligands.Involvement of nuclear protein C23 in activation of EGFR signaling in cervical cancer.The implications and mechanisms of the extra-nuclear nucleolin in the esophageal squamous cell carcinomas.Nucleolin promotes TGF-β signaling initiation via TGF-β receptor I in glioblastoma.Epithelial-mesenchymal transition in human gastric cancer cell lines induced by TNF-α-inducing protein of Helicobacter pylori.The pseudopeptide HB-19 binds to cell surface nucleolin and inhibits angiogenesis.Multivalent pseudopeptides targeting cell surface nucleoproteins inhibit cancer cell invasion through tissue inhibitor of metalloproteinases 3 (TIMP-3) release.Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis.Synthesis and evaluation of an (18) F-labeled derivative of F3 for targeting surface-expressed nucleolin in cancer and tumor endothelial cells.Overexpression of nucleolin and different expression sites both related to the prognosis of gastric cancer.Targeted therapy of human glioblastoma via delivery of a toxin through a peptide directed to cell surface nucleolin.Glycosilated nucleolin as marker for human gliomas.Targeting nucleolin for better survival in diffuse large B-cell lymphoma.The nuclear translocation of endostatin is mediated by its receptor nucleolin in endothelial cells.Anticancer activity and antibody-dependent cell-mediated cytotoxicity of novel anti-nucleolin antibodies.
P2860
Q28287657-2C182B47-5AA3-4C7C-BE2F-50601B746170Q34047719-FECEEA77-36EC-4648-8F46-7F7AF6708DA3Q34221688-71BBB616-6D81-48FC-87D7-7A40728DE78DQ34475097-047FA5DF-844F-4E0A-AF41-30C464BB14C9Q35672973-D061C8F0-FA16-46BC-80FC-6305523D19F6Q35690196-1B415213-CF99-440D-8D6B-6AB0C4C4D733Q36140779-48DDAADF-EF46-41C1-BB51-3A008D7DE492Q36508636-24509ACA-FC9E-4084-82F9-E22212682BE0Q36561693-1AD46242-B15D-49C6-A1C2-B6FB911E0763Q36907845-158A6C20-03DA-45DB-8E52-D286061FA4CDQ37256221-D68A07BF-A9A1-4B10-AE64-F4490CF5C2CDQ37698301-92F560A6-A7EA-4C1E-9229-77AA0EB8355EQ38845264-5047E79D-2531-4829-B547-C5B552C1E373Q38915468-2C418CD2-CD16-41DC-BC35-8AF2717BAF59Q39010093-C8D010A6-5212-4D9B-A842-635C3FA3D0CDQ39061507-7763CA9D-00A2-4FA2-8ADA-2236632E21F6Q39232685-7A4DBB79-FB8E-4E9D-959A-2EB762669BDFQ39251761-27B4B715-463E-4868-B428-73FBAA46AD67Q39368829-BF713C13-CC98-4379-BDE0-A6D74BE976DAQ41593876-14B26D14-B962-46BF-ACC8-97DFF86C68CDQ44428129-2BC66065-C584-4226-B8B5-D39EF7138D97Q47755537-9F25A308-2ADA-4E78-87B9-A66F247948ECQ48883976-4C6CF1A4-FB57-49D7-AAD0-248EA1B8F988Q52583133-3FABB066-1145-4702-A5A4-73537F033D7CQ54077957-47C6847C-8859-49B2-A3DE-6196BA27366EQ54988217-316E9401-6B11-4878-8087-59FD8A6F8CE9
P2860
Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Targeting surface nucleolin wi ...... the malignant tumor cell type
@ast
Targeting surface nucleolin wi ...... the malignant tumor cell type
@en
type
label
Targeting surface nucleolin wi ...... the malignant tumor cell type
@ast
Targeting surface nucleolin wi ...... the malignant tumor cell type
@en
prefLabel
Targeting surface nucleolin wi ...... the malignant tumor cell type
@ast
Targeting surface nucleolin wi ...... the malignant tumor cell type
@en
P2093
P2860
P356
P1433
P1476
Targeting surface nucleolin wi ...... the malignant tumor cell type
@en
P2093
Ara G Hovanessian
Bernard Krust
Calaiselvy Soundaramourty
Diala El Khoury
Isabelle Nondier
P2860
P2888
P356
10.1186/1471-2407-11-333
P407
P577
2011-08-03T00:00:00Z
P5875
P6179
1022408702